Preclinical and clinical development of DNA vaccines for prostate cancer.

Colluru, V T; Johnson, Laura E; Olson, Brian M; McNeel, Douglas G

Colluru, V T; Johnson, Laura E; Olson, Brian M; McNeel, Douglas G.

Affiliation

Colluru VT; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI.
Johnson LE; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI.
Olson BM; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI.
McNeel DG; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI. Electronic address: dm3@medicine.wisc.edu.

Urol Oncol ; 34(4): 193-204, 2016 Apr.

Article in En | MEDLINE | ID: mdl-24332642

Subject(s)

Cancer Vaccines/immunology; Immunotherapy/methods; Prostatic Neoplasms/therapy; Vaccines, DNA/immunology; Animals; Cancer Vaccines/administration & dosage; Cancer Vaccines/chemistry; Clinical Trials, Phase III as Topic; Humans; Male; Prostatic Neoplasms/immunology; Randomized Controlled Trials as Topic; Vaccines, DNA/administration & dosage; Vaccines, DNA/chemistry

Key words

Clinical trials; DNA vaccines; Prostate cancer; Tumor vaccine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Cancer Vaccines / Vaccines, DNA / Immunotherapy Type of study: Clinical_trials Limits: Animals / Humans / Male Language: En Journal: Urol Oncol Journal subject: NEOPLASIAS / UROLOGIA Year: 2016 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google